SNSS - Sunesis Pharmaceuticals Inc. (SNSS) CEO Dayton Misfeldt on Q1 20189 Results - Earnings Call Transcript
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
Q1 2019 Earnings Conference Call
May 8, 2019 4:30 PM ET
Company Participants
Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development
Dayton Misfeldt - Interim Chief Executive Officer
Judy Fox - Chief Scientific Officer
Deepali Suri - Vice President, Clinical Operations
Conference Call Participants
Marc Frahm - Cowen and Company
Hartaj Singh - Oppenheimer
Presentation
Operator
Good afternoon, ladies and gentlemen and welcome to the Q1 2019 Sunesis Pharmaceuticals Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct